Redhill Biopharma Shares Outstanding 2013-2019 | RDHL

Redhill Biopharma shares outstanding from 2013 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Redhill Biopharma Annual Shares Outstanding
(Millions of Shares)
2018 23
2017 18
2016 13
2015 11
2014 9
2013 6
2012 5
Redhill Biopharma Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 28
Q2 2019 28
Q1 2019 28
Q4 2018 23
Q3 2018 23
Q2 2018 21
Q1 2018 21
Q4 2017 18
Q3 2017 17
Q2 2017 17
Q1 2017 17
Q4 2016 13
Q3 2016 13
Q2 2016 128
Q1 2016 13
Q4 2015 13
Q3 2015 12
Q2 2015 10
Q1 2015 9
Q4 2014 9
Q3 2014 8
Q2 2014 9
Q1 2014 9
Q4 2013 6
Q3 2013 6
Q2 2013 6
Q1 2013 7
Q4 2012 5
Q3 2012 5
Q2 2012 5
Q1 2012 5
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.131B $0.008B
Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It offers the following gastrointestinal products in the United States: Donnatal, a prescription oral adjunctive drug used in the treatment of Irritable Bowel Syndrome (IBS) and acute enterocolitis, as well as EnteraGam, a medical food intended for the dietary management, under medical supervision, of chronic diarrhea and loose stools. Its clinical-stage pipeline includes: TALICIA (RHB-105), an oral combination therapy for the treatment of Helicobacter pylori infection; RHB-104, an oral combination therapy for the treatment of Crohn's disease; BEKINDA (RHB-102), a once-daily oral pill formulation of ondansetron; RHB-106; YELIVA (ABC294640); MESUPRON, and RIZAPORT (RHB-103).
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.924B 38.83
Takeda Pharmaceutical (TAK) Japan $61.813B 9.77
Astellas Pharma (ALPMY) Japan $32.875B 16.42
Eisai (ESALY) Japan $21.999B 42.41
Merck (MKGAF) Germany $16.989B 23.18
Grifols, S.A (GRFS) Spain $15.869B 20.79
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.133B 431.17
Catalent (CTLT) United States $9.010B 36.65
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.358B 16.93
Jazz Pharmaceuticals (JAZZ) Ireland $8.245B 10.53
STADA ARZNEIMI (STDAF) Germany $5.972B 0.00
IPSEN SA ADR (IPSEY) France $5.862B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.282B 16.07
Arrowhead Pharmaceuticals (ARWR) United States $4.270B 64.65
Evotec AG (EVTCY) Germany $4.074B 65.85
United Therapeutics (UTHR) United States $3.920B 0.00
Nektar Therapeutics (NKTR) United States $3.717B 0.00
FibroGen (FGEN) United States $3.647B 107.18
Sage Therapeutics (SAGE) United States $3.525B 0.00
PTC Therapeutics (PTCT) United States $3.200B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.198B 11.77
ChemoCentryx (CCXI) United States $2.396B 0.00
Zogenix (ZGNX) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.119B 0.00
Heron Therapeutics (HRTX) United States $2.035B 0.00
Tilray (TLRY) Canada $1.985B 0.00
Xencor (XNCR) United States $1.947B 59.19
Ironwood Pharmaceuticals (IRWD) United States $1.940B 61.85
Pacira Pharmaceuticals (PCRX) United States $1.828B 54.09
USANA Health Sciences (USNA) United States $1.608B 17.16
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.492B 18.13
Theravance Biopharma (TBPH) Cayman Islands $1.487B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.415B 9.65
Endo (ENDP) Ireland $1.343B 2.47
Enanta Pharmaceuticals (ENTA) United States $1.087B 24.71
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Karyopharm Therapeutics (KPTI) United States $1.036B 0.00
Dermira (DERM) United States $1.020B 0.00
Aerie Pharmaceuticals (AERI) United States $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.943B 0.00
Radius Health (RDUS) United States $0.870B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.671B 0.00
ImmunoGen (IMGN) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.501B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.467B 0.00
Organogenesis Holdings (ORGO) United States $0.459B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.434B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Siga Technologies (SIGA) United States $0.418B 9.56
BioCryst Pharmaceuticals (BCRX) United States $0.417B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.415B 17.91
Catalyst Pharmaceuticals (CPRX) United States $0.410B 49.75
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Recro Pharma (REPH) United States $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.20
Harpoon Therapeutics (HARP) United States $0.360B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.258B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.256B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
IMV INC (IMV) Canada $0.212B 0.00
Jounce Therapeutics (JNCE) United States $0.210B 2.80
La Jolla Pharmaceutical (LJPC) United States $0.206B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 33.23
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Xeris Pharmaceuticals (XERS) United States $0.155B 0.00
CannTrust Holdings (CTST) Canada $0.150B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.139B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
CV Sciences (CVSI) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.095B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.094B 0.00
PolarityTE (PTE) United States $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.73
CTI BioPharma (CTIC) United States $0.074B 0.00
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.062B 15.39
Nivalis Therapeutics (ALPN) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
VAXART, INC (VXRT) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Novan (NOVN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
Heat Biologics (HTBX) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00